Skip to main content

Advertisement

Table 1 Correlation between lymphovascular invasion and clinicopathologic characteristics in gastric carcinoma

From: The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China

Variables Lymphovascular invasion
All cases Absence Presence P value*
Sex     0.955
  Female 354 229 (64.7%) 125 (35.3%)  
  Male 794 515 (64.9%) 279 (35.1%)  
Age at diagnosis (years)     0.458
  <60 574 378 (65.9%) 196 (34.1%)  
  ≥60 574 366 (63.8%) 208 (36.2%)  
CEA     0.665
  Normal 791 525 (66.4%) 266 (33.6%)  
  Elevated 157 107(68.2%) 50 (31.8%)  
CA19-9     0.004
  Normal 707 487 (68.9%) 220 (31.1%)  
  Elevated 195 113 (57.9%) 82 (42.1%)  
Size (diameter), cm     <0.0001
  ≤5 697 487 (69.9%) 210 (30.1%)  
  >5 451 257 (57.0%) 194 (43.0%)  
Lauren classification     0.004
  Diffuse 585 356 (60.9%) 229 (39.1%)  
  Mixed/ Intestinal 563 388 (68.9%) 175 (31.1%)  
Differentiation     <0.0001
  Well/moderate 435 331 (76.1%) 104 (23.9%)  
  Poor/undifferentiated 713 413 (57.9%) 300 (42.1%)  
Gastric wall invasion     <0. 0001
  T1/T2 150 140 (93.3%) 10 (6.7%)  
  T3/T4 998 604 (60.5%) 394 (39.5%)  
Nodal metastasis     <0.0001
  N0 377 322 (85.4%) 55 (14.6%)  
  N1-N3 771 422 (54.7%) 349 (45.3%)  
Distant metastasis     <0.0001
  M0 1003 679 (67.7%) 324 (32.4%)  
  M1 145 65 (44.8%) 80 (55.2%)  
TNM stage     <0.0001
  I/II 486 409 (84.2%) 77 (15.8%)  
  III/ IV 662 335 (50.6%) 327 (49.4%)  
  1. *Chi-square test; Preoperative serum CEA was measured in 948 patients; Preoperative serum CA19-9 was measured in 902 patients; CEA indicates carcinoembryonic antigen; CA19-9 indicates carbohydrate antigen 19-9.